Nuclear transport of galectin-3 and its therapeutic implications

被引:63
作者
Funasaka, Tatsuyoshi [1 ]
Raz, Avraham [2 ]
Nangia-Makker, Pratima [3 ,4 ]
机构
[1] Nanzando Pharmacies Co, Minato Ku, Tokyo 1080074, Japan
[2] Wayne State Univ, Dept Oncol, Sch Med, Detroit, MI 48202 USA
[3] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48202 USA
[4] John D Dingell VA Med Ctr, Detroit, MI 48201 USA
基金
美国国家卫生研究院;
关键词
Galectin-3; Nuclear cytoplasmic transport; Beta catenin; GLYCOGEN-SYNTHASE KINASE-3-BETA; CARBOHYDRATE-BINDING PROTEIN-35; BETA-CATENIN TRANSACTIVATION; SQUAMOUS-CELL CARCINOMA; PORE COMPLEX STRUCTURE; WNT SIGNALING PATHWAY; BREAST-CANCER; PROSTATE-CANCER; DRUG-RESISTANCE; CITRUS PECTIN;
D O I
10.1016/j.semcancer.2014.03.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Galectin-3, a member of beta-galactoside-binding gene family is a multi-functional protein, which regulates pleiotropic biological functions such as cell growth, cell adhesion, cell-cell interactions, apoptosis, angiogenesis and mRNA processing. Its unique structure enables it to interact with a plethora of ligands in a carbohydrate dependent or independent manner. Galectin-3 is mainly a cytosolic protein, but can easily traverse the intracellular and plasma membranes to translocate into the nucleus, mitochondria or get externalized. Depending on the cell type, specific experimental conditions in vitro, cancer type and stage, galectin-3 has been reported to be exclusively cytoplasmic, predominantly nuclear or distributed between the two compartments. In this review we have summarized the dynamics of galectin-3 shuttling between the nucleus and the cytoplasm, the nuclear transport mechanisms of galectin-3, how its specific interactions with the members of beta-catenin signaling pathways affect tumor progression, and its implications as a therapeutic target. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 160 条
  • [31] Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin
    Dechat, Thomas
    Pfleghaar, Katrin
    Sengupta, Kaushik
    Shimi, Takeshi
    Shumaker, Dale K.
    Solimando, Liliana
    Goldman, Robert D.
    [J]. GENES & DEVELOPMENT, 2008, 22 (07) : 832 - 853
  • [32] When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
    Di Lella, Santiago
    Sundblad, Victoria
    Cerliani, Juan P.
    Guardia, Carlos M.
    Estrin, Dario A.
    Vasta, Gerardo R.
    Rabinovich, Gabriel A.
    [J]. BIOCHEMISTRY, 2011, 50 (37) : 7842 - 7857
  • [33] Galectin-3:: An open-ended story
    Dumic, J
    Dabelic, S
    Flögel, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (04): : 616 - 635
  • [34] Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity
    Elad-Sfadia, G
    Haklai, R
    Balan, E
    Kloog, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) : 34922 - 34930
  • [35] Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP
    Ellerhorst, JA
    Stephens, LC
    Nguyen, T
    Xu, XC
    [J]. PROSTATE, 2002, 50 (01) : 64 - 70
  • [36] Role of nucleoporin induction in releasing an mRNA nuclear export block
    Enninga, J
    Levy, DE
    Blobel, G
    Fontoura, BMA
    [J]. SCIENCE, 2002, 295 (5559) : 1523 - 1525
  • [37] Regulation of tumor suppressors by nuclear-cytoplasmic shuttling
    Fabbro, M
    Henderson, BR
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 282 (02) : 59 - 69
  • [38] Differential expression of galectin-3, β-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands
    Ferrazzo, K. L.
    Neto, M. M.
    dos Santos, E.
    Pinto, D. dos Santos
    de Sousa, S. O. M.
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (09) : 701 - 707
  • [39] Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways
    Fukumori, T
    Takenaka, Y
    Oka, N
    Yoshii, T
    Hogan, V
    Inohara, H
    Kanayama, HO
    Kim, HRC
    Raz, A
    [J]. CANCER RESEARCH, 2004, 64 (10) : 3376 - 3379
  • [40] The role of galectin-3 in cancer drug resistance
    Fukumori, Tomoharu
    Kanayama, Hiro-omi
    Raz, Avraham
    [J]. DRUG RESISTANCE UPDATES, 2007, 10 (03) : 101 - 108